Cargando…
Improving the Treatment of Acute Lymphoblastic Leukemia
[Image: see text] l-Asparaginase (EC 3.5.1.1) was first used as a component of combination drug therapies to treat acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow, almost 50 years ago. Administering this enzyme to reduce asparagine levels in the blood is a cornerstone of mo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American
Chemical Society
2020
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497903/ https://www.ncbi.nlm.nih.gov/pubmed/32786406 http://dx.doi.org/10.1021/acs.biochem.0c00354 |